| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies
|
Guo, Christina W.
|
|
|
124 |
C |
p. 15-24
|
artikel
|
| 2 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
|
Chiang, Nai-Jung
|
|
|
124 |
C |
p. 123-130
|
artikel
|
| 3 |
A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours
|
Martin, Enrico
|
|
|
124 |
C |
p. 77-87
|
artikel
|
| 4 |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang, Ching-Yao
|
|
|
124 |
C |
p. 110-122
|
artikel
|
| 5 |
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
|
Kim, Kyeong J.
|
|
|
124 |
C |
p. 161-169
|
artikel
|
| 6 |
Causes of cancer: Perceptions vs. the scientific evidence
|
Bandara, Priyanka
|
|
|
124 |
C |
p. 214-216
|
artikel
|
| 7 |
Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants
|
Flaum, Nicola
|
|
|
124 |
C |
p. 88-90
|
artikel
|
| 8 |
Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants
|
Summers, Matthew G.
|
|
|
124 |
C |
p. 56-63
|
artikel
|
| 9 |
Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
|
Jones, David A.
|
|
|
124 |
C |
p. 178-185
|
artikel
|
| 10 |
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma
|
Thomas, Anne
|
|
|
124 |
C |
p. 131-141
|
artikel
|
| 11 |
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
|
Schmitz, Christine
|
|
|
124 |
C |
p. 25-36
|
artikel
|
| 12 |
Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial
|
Hammel, Pascal
|
|
|
124 |
C |
p. 91-101
|
artikel
|
| 13 |
Increased risk for second primary rectal cancer after pelvic radiation therapy
|
Rombouts, Anouk J.M.
|
|
|
124 |
C |
p. 142-151
|
artikel
|
| 14 |
Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis
|
Mayinger, Michael
|
|
|
124 |
C |
p. 194-203
|
artikel
|
| 15 |
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer
|
Wagner, Anna D.
|
|
|
124 |
C |
p. 67-76
|
artikel
|
| 16 |
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma
|
Tas, M.L.
|
|
|
124 |
C |
p. 47-55
|
artikel
|
| 17 |
New evidence confirms that reproductive risk factors can be used to stratify breast cancer risks: Implications for a new population screening paradigm
|
Evans, D. Gareth
|
|
|
124 |
C |
p. 204-206
|
artikel
|
| 18 |
Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study
|
Loopik, Diede L.
|
|
|
124 |
C |
p. 102-109
|
artikel
|
| 19 |
Polymorphism within the 3′ untranslated region of denticleless E3 ubiquitin protein ligase homologue and survival in acral melanoma
|
Joob, Beuy
|
|
|
124 |
C |
p. 64
|
artikel
|
| 20 |
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma
|
Hartmann, Joerg T.
|
|
|
124 |
C |
p. 152-160
|
artikel
|
| 21 |
Response to letter: Causes of cancer: Perceptions versus the scientific evidence by Bandara and Carpenter
|
Shahab, Lion
|
|
|
124 |
C |
p. 217-218
|
artikel
|
| 22 |
Response to: Polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog and survival in acral melanoma
|
Dai, Jie
|
|
|
124 |
C |
p. 65-66
|
artikel
|
| 23 |
Risk-tailored starting age of breast cancer screening based on women's reproductive profile: A nationwide cohort study
|
Mukama, Trasias
|
|
|
124 |
C |
p. 207-213
|
artikel
|
| 24 |
Statins use and prostate cancer mortality
|
Lai, Shih-Wei
|
|
|
124 |
C |
p. 219-220
|
artikel
|
| 25 |
The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life: A randomised controlled trial
|
Vanbutsele, Gaëlle
|
|
|
124 |
C |
p. 186-193
|
artikel
|
| 26 |
The impact of body composition parameters on severe toxicity of nivolumab
|
Hirsch, Laure
|
|
|
124 |
C |
p. 170-177
|
artikel
|
| 27 |
Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France
|
Barin-Le Guellec, Chantal
|
|
|
124 |
C |
p. 37-46
|
artikel
|
| 28 |
Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis
|
Wang, Sufei
|
|
|
124 |
C |
p. 1-14
|
artikel
|
Tijdschrift beschrijving